BST-2 Binding with Cellular MT1-MMP Blocks Cell Growth and Migration Via Decreasing MMP2 Activity
Overview
Cell Biology
Authors
Affiliations
MT1-MMP (membrane type 1-matrix metalloproteinase) plays important roles in cell growth and tumor invasion via mediating cleavage of MMP2/gelatinase A and a variety of substrates including type I collagen. BST-2 (bone marrow stromal cell antigen 2) is a membrane tetherin whose expression dramatically reduces the release of a broad range of enveloped viruses including HIV from infected cells. In this study, we provided evidence that both transient and IFN-α induced BST-2 could decrease the activity of MMP2 via binding to cellular MT1-MMP on its C-terminus and inhibiting its proteolytic activity; and finally block cell growth and migration. Zymography gel and Western blot experiments demonstrated that BST-2 decreased MMP2 activity, but no effect on the expression of MMP2 and MT1-MMP genes. Confocal and immunoprecipitation data showed that BST-2 co-localized and interacted with MT1-MMP. This interaction inhibited the proteolytic enzyme activity of MT1-MMP, and blocked the activation of proMMP2. Experimental results of C-terminus deletion mutant of MT1-MMP showed that activity of MMP2 was no change and also no interaction existed between the mutant and BST-2 after co-transfection with the mutant and BST-2. It meant that C-terminus of MT1-MMP played a key role in the interaction with BST-2. In addition, cell growth in 3D type I collagen gel lattice and cell migration were all inhibited by BST-2. Taken together, BST-2, as a membrane protein and a tetherin of enveloped viruses, was a novel inhibitor of MT1-MMP and could be considerable as an inhibitor of cancer cell growth and migration on clinic.
Jiang L, Wang S, Xia X, Zhang T, Wang X, Zeng F Biochem Genet. 2024; 63(1):354-377.
PMID: 38441813 DOI: 10.1007/s10528-024-10666-z.
In Silico Analysis of Genes Associated with the Pathogenesis of Odontogenic Keratocyst.
Ramirez-Martinez C, Legorreta-Villegas I, Mejia-Velazquez C, Portilla-Robertson J, Gaitan-Cepeda L, Paramo-Sanchez J Int J Mol Sci. 2024; 25(4).
PMID: 38397053 PMC: 10889808. DOI: 10.3390/ijms25042379.
Yu H, Bian Q, Wang X, Wang X, Lai L, Wu Z Oncol Rep. 2024; 51(3).
PMID: 38240088 PMC: 10828922. DOI: 10.3892/or.2024.8704.
Yamamoto A, Morioki H, Nakae T, Miyake Y, Harada T, Noda S FASEB J. 2020; 35(2):e21158.
PMID: 33150680 PMC: 7821213. DOI: 10.1096/fj.202001820R.
Servage K, Stefanius K, Gray H, Orth K Sci Rep. 2020; 10(1):7713.
PMID: 32382024 PMC: 7205864. DOI: 10.1038/s41598-020-64718-6.